Hexobarbital Production Cost Reports

The report provides a detailed analysis essential for establishing a hexobarbital production plant. It encompasses all critical aspects necessary for hexobarbital production, including the cost of hexobarbital production, hexobarbital plant cost, hexobarbital production costs, and the overall hexobarbital production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a hexobarbital production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Hexobarbital is a rapid-acting, short-duration barbiturate derivative used in industrial and scientific settings for pharmaceutical and biomedical research. It functions as a reference compound in drug metabolism and pharmacokinetic studies, helping researchers evaluate how drugs are processed by the liver and how different compounds influence metabolic pathways. Hexobarbital is also used in toxicology and pharmacology studies to investigate central nervous system depressant effects and to screen the activity of hepatic enzymes, mainly in studies involving cytochrome P450 enzyme systems. Additionally, pharmaceutical companies utilise it in preclinical drug development to study enzyme induction, drug interactions, and the metabolic effects of new therapeutic compounds.

The market growth of hexobarbital is driven by the increasing demand for barbiturate-based sedatives and anaesthetics in the pharmaceutical sector, mainly for research, anaesthesia, and neurological disorder management. The rising prevalence of neurological conditions such as epilepsy, insomnia, and anxiety disorders sustains the need for barbiturate drugs in certain clinical situations where alternative medications are less effective. The growing number of surgical procedures and expanding healthcare infrastructure globally boost the demand for short-acting anaesthetic agents. Increased pharmaceutical research and drug development activities, along with advancements in formulation technologies, also support market growth.

Furthermore, factors such as ageing populations, increasing healthcare expenditure, and continued use of barbiturates in specialised medical and veterinary applications contribute to the steady demand for hexobarbital and related compounds. However, strict regulatory control impacts industrial hexobarbital procurement, as hexobarbital belongs to the barbiturate class of drugs and is often regulated due to its potential for misuse, requiring special licenses and compliance with pharmaceutical regulations.

Raw Material for Hexobarbital Production

According to the hexobarbital production plant project report, the various raw materials for hexobarbital production include methyl(cyclohexen-1-yl)cyanoacetic ester and dicyanodiamide.

Production Process of Hexobarbital

The extensive hexobarbital production cost report consists of the following major industrial production process:

1. Production via a multi-step synthesis: The production process of hexobarbital occurs through a multi-step synthesis starting with the condensation of methyl(cyclohexen-1-yl)cyanoacetic ester and dicyanodiamide to form 5-(cyclohexen-1-yl)-5-methyl-2,6-diimino-3-cyanobarbituric acid. The reaction is followed by N-methylation using dimethyl sulfate to introduce the 1,3-dimethyl groups on the barbituric ring. The intermediate undergoes hydrolysis with 25% sulfuric acid to remove cyano and imino functionalities, producing the final product.

Properties of Hexobarbital

Hexobarbital (C12H16N2O3, molecular weight 236.27 g/mol) is a barbituric acid derivative appearing as white or colourless light-sensitive crystals (mp 145-147 degree Celsius, bp ~379 degree Celsius, density ~1.16 g/cm³). It has low water solubility (~435 mg/L) but higher as its sodium salt at pH 11.5; it requires cool storage (2-8 degree Celsius) due to volatility (flash point 11 degree Celsius). It shows moderate lipophilicity (logP 1.5-1.98), acidity (pKa ~8.2), one H-bond donor, three acceptors, TPSA 66.5 Ų, and low rotational flexibility (1 bond), which makes it stable under standard conditions yet prone to pink discolouration from light exposure.